288 related articles for article (PubMed ID: 11878909)
1. Targeted therapy of respiratory syncytial virus in African green monkeys by intranasally administered 2-5A antisense.
Leaman DW; Longano FJ; Okicki JR; Soike KF; Torrence PF; Silverman RH; Cramer H
Virology; 2002 Jan; 292(1):70-7. PubMed ID: 11878909
[TBL] [Abstract][Full Text] [Related]
2. Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin.
Xu Z; Kuang M; Okicki JR; Cramer H; Chaudhary N
Antiviral Res; 2004 Mar; 61(3):195-206. PubMed ID: 15168801
[TBL] [Abstract][Full Text] [Related]
3. Targeted therapy of respiratory syncytial virus by 2-5A antisense.
Cramer H; Okicki JR; Kuang M; Xu Z
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):497-501. PubMed ID: 16247978
[TBL] [Abstract][Full Text] [Related]
4. 2-5A antisense treatment of respiratory syncytial virus.
Leaman DW
Curr Opin Pharmacol; 2005 Oct; 5(5):502-7. PubMed ID: 16081320
[TBL] [Abstract][Full Text] [Related]
5. 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection.
Barnard DL; Sidwell RW; Xiao W; Player MR; Adah SA; Torrence PF
Antiviral Res; 1999 Apr; 41(3):119-34. PubMed ID: 10320045
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of respiratory syncytial virus replication using a 2-5A-antisense chimera targeted to signals within the virus genomic RNA.
Player MR; Barnard DL; Torrence PF
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8874-9. PubMed ID: 9671772
[TBL] [Abstract][Full Text] [Related]
7. Targeting RNA decay with 2',5' oligoadenylate-antisense in respiratory syncytial virus-infected cells.
Cirino NM; Li G; Xiao W; Torrence PF; Silverman RH
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1937-42. PubMed ID: 9050883
[TBL] [Abstract][Full Text] [Related]
8. 2-5A-antisense chimeras: inhibitors of respiratory syncytial virus infection.
Torrence PF
Curr Opin Mol Ther; 1999 Jun; 1(3):307-15. PubMed ID: 11713795
[TBL] [Abstract][Full Text] [Related]
9. Chimeric subgroup A respiratory syncytial virus with the glycoproteins substituted by those of subgroup B and RSV without the M2-2 gene are attenuated in African green monkeys.
Cheng X; Zhou H; Tang RS; Munoz MG; Jin H
Virology; 2001 Apr; 283(1):59-68. PubMed ID: 11312662
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of respiratory syncytial virus in cultured cells by nucleocapsid gene targeted deoxyribozyme (DNAzyme).
Xie YY; Zhao XD; Jiang LP; Liu HL; Wang LJ; Fang P; Shen KL; Xie ZD; Wu YP; Yang XQ
Antiviral Res; 2006 Aug; 71(1):31-41. PubMed ID: 16687180
[TBL] [Abstract][Full Text] [Related]
11. Recruiting the 2-5A system for antisense therapeutics.
Torrence PF; Xiao W; Li G; Cramer H; Player MR; Silverman RH
Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):203-6. PubMed ID: 9212911
[No Abstract] [Full Text] [Related]
12. The quest for an efficacious antiviral for respiratory syncytial virus.
Torrence PF; Powell LD
Antivir Chem Chemother; 2002 Nov; 13(6):325-44. PubMed ID: 12718405
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of respiratory syncytial virus of subgroups A and B using deoxyribozyme DZ1133 in mice.
Zhou J; Yang XQ; Xie YY; Zhao XD; Jiang LP; Wang LJ; Cui YX
Virus Res; 2007 Dec; 130(1-2):241-8. PubMed ID: 17804108
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of respiratory syncytial virus replication by antisense oligodeoxyribonucleotides.
Jairath S; Vargas PB; Hamlin HA; Field AK; Kilkuskie RE
Antiviral Res; 1997 Feb; 33(3):201-13. PubMed ID: 9037376
[TBL] [Abstract][Full Text] [Related]
15. Controlling gene expression with 2-5A antisense.
Leaman DW; Cramer H
Methods; 1999 Jul; 18(3):252-65. PubMed ID: 10454983
[TBL] [Abstract][Full Text] [Related]
16. [In vitro inhibitory mechanism of respiratory syncytial virus with solution prescription of zhidanhuayu].
Liu YH; Hou AC; Zhao GC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):486-7. PubMed ID: 19544654
[TBL] [Abstract][Full Text] [Related]
17. Recombinant respiratory syncytial viruses with deletions in the NS1, NS2, SH, and M2-2 genes are attenuated in vitro and in vivo.
Jin H; Zhou H; Cheng X; Tang R; Munoz M; Nguyen N
Virology; 2000 Jul; 273(1):210-8. PubMed ID: 10891423
[TBL] [Abstract][Full Text] [Related]
18. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.
Bolger G; Lapeyre N; Dansereau N; Lagacé L; Berry G; Klosowski K; Mewhort T; Liuzzi M
Can J Physiol Pharmacol; 2005 Feb; 83(2):198-213. PubMed ID: 15791294
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of respiratory syncytial virus replication in cultured cells by RNA-cleaving DNAzyme].
Zhao CA; Zhao XD; Yu HG; Wu YP; Yang XQ
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):594-7. PubMed ID: 14744382
[TBL] [Abstract][Full Text] [Related]
20. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.
Zhang W; Tripp RA
J Virol; 2008 Dec; 82(24):12221-31. PubMed ID: 18818323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
